Schedule 13D ownership disclosure
RVL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G6S41R101
Event date: 2021-10-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 23,667,540
- Percent of class
- 28.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171843-21-007470
- Form type
- SC 13D
- Filer
- Altchem Ltd
- CIK
- CIK 1752864
- Filed
- Nov 03, 2021
- Reporting period
- Oct 12, 2021
- Description
- Schedule 13D beneficial ownership